和康生

-0.65 (-1.75%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

36.4059成交張數11.20本益比2.18股價淨值比5.49%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度	單季 EPS	年增	近四季 EPS	歸屬母公司淨利(億)	淨利率	ROE(季)	ROE(近四季)
2026Q2	0.88	35.4%	3.25	0.79	35.8%	5.06%	20.00%
2026Q1	0.59	11.3%	3.02	0.53	27.7%	3.34%	17.46%
2025Q4	0.94	62.1%	2.96	0.84	37.3%	5.56%	18.22%
2025Q3	0.84	50.0%	2.60	0.76	37.6%	5.23%	16.67%
2025Q2	0.65	-3.0%	2.32	0.59	28.2%	4.08%	15.17%
2025Q1	0.53	65.6%	2.34	0.47	26.6%	3.30%	14.75%
2024Q4	0.58	205.3%	2.13	0.52	25.5%	3.87%	13.90%
2024Q3	0.56	19.1%	1.74	0.50	28.5%	3.72%	11.49%
2024Q2	0.67	-4.9%	1.65	0.60	34.3%	4.45%	11.12%
2024Q1	0.32	-35.4%	1.68	0.28	22.4%	2.09%	11.11%
2023Q4	0.19	-50.1%	1.86	0.18	11.9%	1.29%	12.48%
2023Q3	0.47	-19.6%	2.05	0.41	25.9%	3.08%	14.62%
2023Q2	0.70	89.3%	2.17	0.62	36.5%	4.69%	15.26%
2023Q1	0.50	111.9%	1.83	0.44	31.1%	3.37%	13.02%
2022Q4	0.38	158.8%	1.57	0.43	26.3%	3.40%	11.44%
2022Q3	0.58	60.8%	1.34	0.42	25.9%	3.43%	9.26%
2022Q2	0.37	38.7%	1.12	0.33	21.7%	2.83%	9.37%
2022Q1	0.23	-12.9%	1.01	0.21	16.7%	1.78%	8.46%
2021Q4	0.15	-41.3%	1.05	0.14	9.8%	1.22%	8.76%
2021Q3	0.36	133.3%	1.15	0.31	22.3%	3.04%	9.59%
2021Q2	0.27	6.9%	0.94	0.21	17.7%	2.40%	8.73%
2021Q1	0.27	106.7%	0.93	0.22	19.5%	2.48%	8.57%
2020Q4	0.25	163.4%	0.79	0.20	16.6%	2.40%	7.40%
2020Q3	0.16	-35.7%	0.63	0.12	10.6%	1.46%	5.98%
2020Q2	0.25	-23.6%	0.72	0.21	17.6%	2.43%	6.98%
2020Q1	0.13	49.9%	0.80	0.10	9.9%	1.19%	7.42%
2019Q4	0.10	10.1%	0.75	0.07	6.7%	0.88%	7.10%
2019Q3	0.24	7.7%	0.74	0.19	16.2%	2.34%	7.15%
2019Q2	0.33	11.8%	0.73	0.26	20.7%	3.15%	7.09%
2019Q1	0.09	-16.7%	0.69	0.07	7.4%	0.80%	6.70%
2018Q4	0.09	100.0%	0.71	0.07	7.8%	0.88%	6.96%
2018Q3	0.23	136.3%	0.67	0.18	15.6%	2.14%	6.53%
2018Q2	0.29	161.6%	0.54	0.24	20.6%	2.90%	5.39%
2018Q1	0.10	–	0.35	0.08	7.9%	1.06%	3.56%
2017Q4	0.04	25.1%	0.20	0.03	3.1%	0.44%	2.00%
2017Q3	0.10	–	0.19	0.08	7.3%	0.98%	2.01%
2017Q2	0.11	–	0.09	0.09	7.2%	1.09%	0.86%
2017Q1	-0.05	–	-0.07	-0.04	-4.3%	-0.51%	-0.64%
2016Q4	0.03	–	-0.16	0.03	3.3%	0.44%	–
2016Q3	-0.01	–	–	-0.01	-1.5%	-0.17%	–